Cell in Cells
Cell in Cells researches and develops cell therapy products for regenerative medicine through the 3D technology of stem cells.
Funding reportedLast round: Series B
What company datasets say Cell in Cells raised
Funding, as reported
Reported in all15.5Bin the source's currency
Rounds2
Last roundSeries B
Last round dateJul 2021
Investors listed7
3D Technology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Cell in Cells in front of investors. Or tell us what we have wrong.